US pharmacy pricing
Hyrimoz Prices at US Pharmacies
Lowest price found · US pharmacies
$1,254.80/fill
for Hyrimoz, across the pharmacies in our data
US pharmacy prices — 2ml of 40mg/0.4ml
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
 Kroger Pharmacy | $1,254.80Lowest | $1,257.80 | $808.91 |
 Harris Teeter Pharmacy | $1,254.80Lowest | $1,257.80 | $808.91 |
 Walgreens | $1,319.69 | $1,322.69 | $808.91 |
 Publix | $1,328.83 | $1,331.83 | $808.91 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Hyrimoz.
Frequently asked questions
Is Hyrimoz (Hyrimoz) expensive if I don't have insurance?
Our most recent US pharmacy data shows a low of roughly $1,254.80 for Hyrimoz with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.
Does Hyrimoz have a generic equivalent?
Generic and brand-name pricing for Hyrimoz is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
How is the cost of Hyrimoz determined for patients with insurance?
The out-of-pocket cost with insurance depends entirely on your specific plan's formulary and benefit design. Some plans may cover Hyrimoz with a copay or coinsurance, while others may not cover it at all. Contact your insurance provider for details on coverage and your expected cost. If your insurance does not cover the medication, you may still be able to access savings through independent pharmacy discount programs. Some insurance plans may also require you to fill your prescription at a designated specialty pharmacy.
Is a generic version of Hyrimoz available?
As a biologic medication, Hyrimoz does not have a traditional generic. Instead, it is classified as a biosimilar to Humira (adalimumab). This means it is highly similar to the reference product, Humira, with no clinically meaningful differences in safety or effectiveness. Several other biosimilars to Humira, such as Hadlima and Idacio, are also available. The availability of biosimilars can create price competition, potentially lowering costs for patients.
What is Hyrimoz, and what conditions does it treat?
Hyrimoz (adalimumab-adaz) is a tumor necrosis factor (TNF) blocker manufactured by Sandoz. It works by suppressing an overactive immune response and blocking TNF, a protein that drives inflammation. Approved by the FDA, it is used to treat several autoimmune conditions in adults and, for some indications, in children. These include rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, and hidradenitis suppurativa. It is administered as a subcutaneous injection in the thigh or abdomen, avoiding areas of skin that are irritated or damaged. A critical safety note: patients taking Hyrimoz should not receive live vaccines (such as MMR, varicella, or shingles vaccines) due to an increased risk of serious infection.